In a statement, Novo Nordisk President and CEO Mike Doustdar said, Novo Nordisk has always worked to secure affordable access to our innovative medicines, and todays announcement will bring semaglutide medicines to more American patients at a lower cost
law, a pharmacy can compound using a bulk drug substance only if: Problem: Wegovy is under shortage status, but semaglutide sodium salt and other non-approved forms are NOT properly authorized for compounding under FDA rules
This means that for the vast majority of people the medications alone dont work in the long run
Media Mentions & Features : A Users Guide to Therapeutic Psychedelics: From magic mushrooms to MDMA and ayahuasca to ibogaineeverything you need to know before (and after) taking the leap - Oprah Daily, May 6, 2024 Why I Practice Medicine : I'm passionate about helping people access reliable, affordable healthcarewithout stigma or unnecessary barriers
individual response varies, and switching is possible